TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/10/2024
Back to search
Official data from USPTO
STREAMLINED CDX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
STREAMLINED CDX
ST13
US500000088334926Class
35, 42, 44, 45
Filing
88334926
Registration
7093779
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
54
Latest update
10/15/2024
Trademark type
Word
Nice classes
35, 42, 44, 45
Filing date
03/11/2019
Registration date
06/27/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/27/2023
Last transaction
10/15/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/12/2019
First use in commerce
03/12/2019
Drawing code
4
Owner type
03
Owner location
San Diego, CA, US
Examiner
MCGILL, CIERRA
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Invivoscribe, Inc.
Representatives
Sarah W. Matthews Dentons Durham Jones Pinegar
Technical classification
Nice Classes
Class 35Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consultingbusiness managementadvertising and marketing services in the field of pharmaceuticalbiochemistrybiotechnology development; business consultingbusiness managementadvertising and marketing services in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; providing independent review of clinical trials for business purposes
Class 42
Providing medical research and scientific information in the fields of pharmaceuticalsbiochemistrybiotechnologyclinical trials; drug discovery services; pharmaceutical research and development; research and development of new products; research in the fields of biochemistrybiotechnologyclinical trials; consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; reagent sample testing and diagnostic services for others in the fields of science to determine conformity with established certification standards
Class 44
Providing medical information in the fields of pharmaceuticalsbiochemistrybiotechnologyclinical trials
Class 45
Regulatory compliance consulting in the field of reagent sample testing and diagnostic services
Publications
History of USPTO decisions and trademark events.
54 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/10/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/27/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/27/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/20/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/19/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/22/2023
ALIE
ASSIGNED TO LIE
03/22/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/15/2023
DOCK
ASSIGNED TO EXAMINER
01/17/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/17/2022
GNRT
NON-FINAL ACTION E-MAILED
12/17/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
12/17/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/29/2022
IUAF
USE AMENDMENT FILED
11/23/2022
EISU
TEAS STATEMENT OF USE RECEIVED
11/23/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/28/2022
EX5G
SOU EXTENSION 5 GRANTED
06/27/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/27/2022
EXT5
SOU EXTENSION 5 FILED
06/17/2022
EEXT
SOU TEAS EXTENSION RECEIVED
06/17/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/23/2021
EX4G
SOU EXTENSION 4 GRANTED
12/21/2021
EXT4
SOU EXTENSION 4 FILED
12/21/2021
EEXT
SOU TEAS EXTENSION RECEIVED
12/21/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/08/2021
EX3G
SOU EXTENSION 3 GRANTED
07/06/2021
EXT3
SOU EXTENSION 3 FILED
07/06/2021
EEXT
SOU TEAS EXTENSION RECEIVED
07/06/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/06/2021
EX2G
SOU EXTENSION 2 GRANTED
01/04/2021
EXT2
SOU EXTENSION 2 FILED
01/04/2021
EEXT
SOU TEAS EXTENSION RECEIVED
01/04/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/08/2020
EX1G
SOU EXTENSION 1 GRANTED
07/06/2020
EXT1
SOU EXTENSION 1 FILED
07/06/2020
EEXT
SOU TEAS EXTENSION RECEIVED
07/06/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/07/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2019
PUBO
PUBLISHED FOR OPPOSITION
11/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2019
ALIE
ASSIGNED TO LIE
10/03/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/26/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/25/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/24/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/24/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/29/2019
GNRT
NON-FINAL ACTION E-MAILED
03/29/2019
CNRT
NON-FINAL ACTION WRITTEN
03/29/2019
DOCK
ASSIGNED TO EXAMINER
03/29/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/28/2019
NWAP
NEW APPLICATION ENTERED
03/14/2019
Continuous trademark protection
Get notified about every new filing that threatens STREAMLINED CDX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.